German PMS Trial (AWB) to Evaluate Therapy in Reflux Disease and NSAR-Symptoms
Completed
- Conditions
- Gastroesophageal Reflux
- Registration Number
- NCT00567021
- Lead Sponsor
- AstraZeneca
- Brief Summary
This PMS study had the objective to evaluate under ordinary medical care conditions the efficacy and tolerability of esomeprazole in patients who where treated by general practitioners and internists.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 67130
Inclusion Criteria
- Patients with GERD, or NSAID related ulcers, who need treatment with esomeprazole.
Read More
Exclusion Criteria
- Limitations; possible risks; warnings; contraindications mentioned in the SPC.
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To gain further insight into the efficacy of esomeprazole under ordinary medical care conditions in consideration of diagnosis and type of NSAID therapy (if administered). By estimating the proportion of treated subjects without any gastrointestinal symptoms at the end of the observational period 2. by assessing the change in intensity of gastrointestinal symptoms.
- Secondary Outcome Measures
Name Time Method To get further insight into the details of the use, dosage scheme and duration of treatment with esomeprazole in this population